Nisa Investment Advisors
ABOS icon

Nisa Investment Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

Nisa Investment Advisors’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9K Hold
1,229
– – ﹤0.01% 2558
2025
Q4 		$2.59K Hold
1,229
– – ﹤0.01% 2574
2025
Q3 		$2.1K Hold
1,229
– – ﹤0.01% 2608
2025
Q2 		$1.43K Buy
+1,229
New +$1.32K ﹤0.01% 2675
2025
Q1 		– Sell
-356
Closed -$612 – 2983
2024
Q4 		$612 Buy
356
+256
+256% +$616 ﹤0.01% 2788
2024
Q3 		$248 Buy
+100
New +$271 ﹤0.01% 2824

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Nisa Investment Advisors's ABOS Position: Q1 2026 in Review

Nisa Investment Advisors held its Acumen Pharmaceuticals (ABOS) position steady in Q1 2026 at 1,229 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Nisa Investment Advisors first reported a position in ABOS in Q3 2024 and has held it in 6 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Nisa Investment Advisors held 1,229 shares of Acumen Pharmaceuticals worth $2.9K as of Q1 2026.
  • Nisa Investment Advisors left its Acumen Pharmaceuticals share count unchanged in Q1 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2558 holding.
  • Nisa Investment Advisors first reported a position in Acumen Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.